PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
106.92%
Net income growth similar to AVGO's 106.45%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
-1.72%
Negative yoy D&A while AVGO is 2.56%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
1083.33%
Deferred tax of 1083.33% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-2.13%
Both cut yoy SBC, with AVGO at -25.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-68.42%
Both reduce yoy usage, with AVGO at -132.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-60.34%
AR is negative yoy while AVGO is 600.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-243.24%
Both reduce yoy inventory, with AVGO at -107.14%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
245.00%
Some yoy usage while AVGO is negative at -185.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-160.00%
Both negative yoy, with AVGO at -50.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
49.73%
Some CFO growth while AVGO is negative at -53.03%. John Neff would note a short-term liquidity lead over the competitor.
-370.83%
Negative yoy CapEx while AVGO is 7.69%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-154.05%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-73.59%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-769.01%
We reduce yoy invests while AVGO stands at 33.33%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
78.95%
Issuance growth of 78.95% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-0.40%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.